319 related articles for article (PubMed ID: 33822924)
21. [Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation].
Gargiulo G; Valgimigli M
G Ital Cardiol (Rome); 2016 Jun; 17(6 Suppl 2):4S-10. PubMed ID: 27384599
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.
Siontis GCM; Overtchouk P; Cahill TJ; Modine T; Prendergast B; Praz F; Pilgrim T; Petrinic T; Nikolakopoulou A; Salanti G; Søndergaard L; Verma S; Jüni P; Windecker S
Eur Heart J; 2019 Oct; 40(38):3143-3153. PubMed ID: 31329852
[TBL] [Abstract][Full Text] [Related]
23. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
[TBL] [Abstract][Full Text] [Related]
24. What are the remaining limitations of TAVI?
De Biase C; Mastrokostopoulos A; Philippart R; Bonfils L; Berthoumieu P; Dumonteil N
J Cardiovasc Surg (Torino); 2018 Jun; 59(3):373-380. PubMed ID: 29557590
[TBL] [Abstract][Full Text] [Related]
25. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI).
Nijenhuis VJ; Bennaghmouch N; van Kuijk JP; Capodanno D; ten Berg JM
Thromb Haemost; 2015 Apr; 113(4):674-85. PubMed ID: 25653053
[TBL] [Abstract][Full Text] [Related]
26. Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery Departments.
von Scheidt W; Welz A; Pauschinger M; Fischlein T; Schächinger V; Treede H; Zahn R; Hennersdorf M; Albes JM; Bekeredjian R; Beyer M; Brachmann J; Butter C; Bruch L; Dörge H; Eichinger W; Franke UFW; Friedel N; Giesler T; Gradaus R; Hambrecht R; Haude M; Hausmann H; Heintzen MP; Jung W; Kerber S; Mudra H; Nordt T; Pizzulli L; Sack FU; Sack S; Schumacher B; Schymik G; Sechtem U; Stellbrink C; Stumpf C; Hoffmeister HM
Clin Res Cardiol; 2020 Jan; 109(1):1-12. PubMed ID: 31410547
[TBL] [Abstract][Full Text] [Related]
27. [Management of valvular heart disease : ESC/EACTS guidelines 2017].
Haude M
Herz; 2017 Dec; 42(8):715-720. PubMed ID: 29188357
[TBL] [Abstract][Full Text] [Related]
28. Antithrombotic therapy after transcatheter aortic valve replacement.
Kobari Y; Inohara T; Hayashida K;
Cardiovasc Interv Ther; 2023 Jan; 38(1):9-17. PubMed ID: 36115004
[TBL] [Abstract][Full Text] [Related]
29. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
Nijenhuis VJ; Brouwer J; Søndergaard L; Collet JP; Grove EL; Ten Berg JM
Heart; 2019 May; 105(10):742-748. PubMed ID: 30867148
[TBL] [Abstract][Full Text] [Related]
30. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up.
Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y
Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402
[TBL] [Abstract][Full Text] [Related]
31. [Chinese expert consensus on antithrombotic therapy after transcatheter aortic valve implantation].
;
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Feb; 50(2):117-131. PubMed ID: 35172455
[TBL] [Abstract][Full Text] [Related]
32. Subclinical valve thrombosis in transcatheter aortic valve implantation: A systematic review and meta-analysis.
Woldendorp K; Doyle MP; Black D; Ng M; Keech A; Grieve SM; Bannon PG
J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1491-1499.e2. PubMed ID: 32217021
[TBL] [Abstract][Full Text] [Related]
33. "Subclinical" Leaflet Thrombosis in Transcatheter Aortic Valve Implantation: A Latent Risk?
Moral S; Carballo J; Ballesteros E; Panaro A; Evangelista A
Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):512-514. PubMed ID: 27707563
[No Abstract] [Full Text] [Related]
34. Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients.
Sotade OT; Jorm LR; Kushwaha VV; Yu J; Sedrakyan A; Falster MO; Pearson SA
Heart Lung Circ; 2022 Aug; 31(8):1144-1152. PubMed ID: 35637093
[TBL] [Abstract][Full Text] [Related]
35. Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantation.
Guedeney P; Huchet F; Manigold T; Overtchouk P; Rouanet S; Balagny P; Leprince P; Lebreton G; Letocart V; Barthelemy O; Vicaut E; Montalescot G; Guerin P; Collet JP;
Arch Cardiovasc Dis; 2020 May; 113(5):341-349. PubMed ID: 32115397
[TBL] [Abstract][Full Text] [Related]
36. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
Sherwood MW; Vora AN
Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
[TBL] [Abstract][Full Text] [Related]
37. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events.
Rodés-Cabau J; Dauerman HL; Cohen MG; Mehran R; Small EM; Smyth SS; Costa MA; Mega JL; O'Donoghue ML; Ohman EM; Becker RC
J Am Coll Cardiol; 2013 Dec; 62(25):2349-2359. PubMed ID: 23583252
[TBL] [Abstract][Full Text] [Related]
38. [Postacute care after transcatheter aortic valve implantation (TAVI)].
Nechwatal RM; Bestehorn K; Leuschner F; Hagendorff A; Guha M; Schlitt A
Herz; 2021 Apr; 46(Suppl 1):41-47. PubMed ID: 32313970
[TBL] [Abstract][Full Text] [Related]
39. Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
Huchet F; Letocart V; Guerin P; Cueff C; Roy-Giocosa J; Guyomarch-Delasalle B; Jaafar P; Manigold T
Arch Cardiovasc Dis; 2018 Jan; 111(1):25-32. PubMed ID: 28943264
[TBL] [Abstract][Full Text] [Related]
40. Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) Trial.
Inohara T; Otsuka T; Watanabe Y; Shirai S; Tada N; Yamanaka F; Ueno H; Ohno Y; Tabata M; Suzuyama H; Asami M; Yamawaki M; Izumo M; Yamasaki K; Nishina H; Fuku Y; Mizutani K; Yashima F; Yamamoto M; Hayashida K
Contemp Clin Trials; 2023 Nov; 134():107358. PubMed ID: 37852534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
